Technical analysis of MDxHealth S.A. (MDXH): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
MDxHealth SA is a commercial-stage precision diagnostics firm delivering specialized urologic solutions across the globe. Its international footprint includes the United States, various European nations such as the Netherlands, Belgium, Spain, Poland, Italy, and the wider European Union. The company's innovative genomic testing portfolio for prostate cancer comprises SelectMDx, a non-invasive urine test, and ConfirmMDx, an epigenetic diagnostic tool.
Price Performance
| 1 month | -9.38% |
| 3 months | +25.36% |
| Year-to-date | -80.93% |
| 1 year | -81.50% |
| 3 years | -75.95% |
52-Week Range
| 52-week High | $5.33 |
| 52-week Low | $0.40 |
| Avg Volume (90d) | 4.5M |
Technical Indicators
| SMA 50 | $0.57 |
| SMA 200 | $2.00 |
| Beta | 0.38 |
| 30-day Volatility (annualised) | 173.0% |
| Price vs SMA 50 | +18.8% |
| Price vs SMA 200 | -65.9% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $4.92 | |
| 2025-11 | $3.69 | -25.0% |
| 2025-12 | $3.57 | -3.3% |
| 2026-01 | $3.50 | -2.0% |
| 2026-02 | $3.40 | -2.9% |
| 2026-03 | $2.30 | -32.4% |
| 2026-04 | $2.04 | -11.3% |
| 2026-05 | $0.76 | -62.7% |
| 2026-06 | $0.41 | -46.0% |
| 2026-07 | $0.42 | +1.8% |
| 2026-08 | $0.72 | +72.3% |
| 2026-09 | $0.68 | -5.5% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-15 | | |
| 2026-09-15 | | |
| 2026-09-15 | $0.05 | $88M |
| 2026-09-15 | | |
| 2026-09-15 | $0.14 | $2.28B |
| 2026-09-15 | | |
Price
| Price | $0.68 |
| Market Cap | $35M |
| Exchange | NASDAQ |
| Country | BE |
Valuation Ratios
| Price / Book | -2.92 |
| EV / EBITDA | -17.51 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | -7.86 |
| Current Ratio | 1.08 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -2.73 |